[go: up one dir, main page]

AU2020900586A0 - Methods of treatment and related compositions - Google Patents

Methods of treatment and related compositions

Info

Publication number
AU2020900586A0
AU2020900586A0 AU2020900586A AU2020900586A AU2020900586A0 AU 2020900586 A0 AU2020900586 A0 AU 2020900586A0 AU 2020900586 A AU2020900586 A AU 2020900586A AU 2020900586 A AU2020900586 A AU 2020900586A AU 2020900586 A0 AU2020900586 A0 AU 2020900586A0
Authority
AU
Australia
Prior art keywords
treatment
methods
related compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020900586A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ascend Biopharmaceuticals Pty Ltd
Original Assignee
Ascend Biopharmaceuticals Pty Ltd
Filing date
Publication date
Application filed by Ascend Biopharmaceuticals Pty Ltd filed Critical Ascend Biopharmaceuticals Pty Ltd
Publication of AU2020900586A0 publication Critical patent/AU2020900586A0/en
Priority to PCT/AU2021/050167 priority Critical patent/WO2021168516A1/en
Priority to JP2022552219A priority patent/JP2023520747A/en
Priority to KR1020227033881A priority patent/KR20230016162A/en
Priority to EP21759010.8A priority patent/EP4110369A4/en
Priority to CA3173253A priority patent/CA3173253A1/en
Priority to CN202180031240.6A priority patent/CN116075316A/en
Priority to AU2021226133A priority patent/AU2021226133A1/en
Priority to US17/430,171 priority patent/US11505579B2/en
Priority to US18/048,745 priority patent/US20230183297A1/en
Abandoned legal-status Critical Current

Links

AU2020900586A 2020-02-28 2020-02-28 Methods of treatment and related compositions Abandoned AU2020900586A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
PCT/AU2021/050167 WO2021168516A1 (en) 2020-02-28 2021-02-26 Methods of treatment and related compositions
JP2022552219A JP2023520747A (en) 2020-02-28 2021-02-26 Methods of treatment and related compositions
KR1020227033881A KR20230016162A (en) 2020-02-28 2021-02-26 Treatment methods and related compositions
EP21759010.8A EP4110369A4 (en) 2020-02-28 2021-02-26 Methods of treatment and related compositions
CA3173253A CA3173253A1 (en) 2020-02-28 2021-02-26 Methods of treatment and related compositions
CN202180031240.6A CN116075316A (en) 2020-02-28 2021-02-26 Methods of treatment and related compositions
AU2021226133A AU2021226133A1 (en) 2020-02-28 2021-02-26 Methods of treatment and related compositions
US17/430,171 US11505579B2 (en) 2020-02-28 2021-02-26 Methods of treatment and related compositions
US18/048,745 US20230183297A1 (en) 2020-02-28 2022-10-21 Methods of treatment and related compositions

Publications (1)

Publication Number Publication Date
AU2020900586A0 true AU2020900586A0 (en) 2020-03-12

Family

ID=

Similar Documents

Publication Publication Date Title
EP4110369A4 (en) Methods of treatment and related compositions
EP4319741A4 (en) Compositions and methods for the treatment of cancer
EP4284272A4 (en) Compositions and methods for sustained treatment of pain
EP4142740A4 (en) Compositions and methods of use thereof
EP4381022A4 (en) Compositions and methods of use thereof
EP4138852A4 (en) Compositions and methods for the treatment of pain
EP4100029A4 (en) Compositions and methods of use thereof for treatment of mastitis
EP4216938A4 (en) Compositions and methods for the treatment of hair loss and other conditions
AU2020900813A0 (en) Methods of treatment and related compositions
AU2020900586A0 (en) Methods of treatment and related compositions
AU2022902622A0 (en) Methods of treatment and related compositions
EP3976115A4 (en) Compositions and methods for treatment of hemochromatosis
HK40115056A (en) Compositions and methods for the treatment of proteopathies
HK40090686A (en) Methods and compositions for the treatment of sars-cov-2
HK40113718A (en) Compositions and methods for treatment of sars cov-2
HK40111951A (en) Compositions and methods for treatment of melanoma
HK40110647A (en) Compositions and methods for treatment of melanoma
HK40105345A (en) Compositions and methods for treatment of cancer
HK40115640A (en) Prekallikrein-modulating compositions and methods of use thereof
HK40114450A (en) Angiotensinogen-modulating compositions and methods of use thereof
HK40086642A (en) Compositions and methods for treatment of cancer
EP4110923A4 (en) Methods and compositions for treatment of apc-deficient cancer
HK40101479A (en) Compositions and methods of use thereof
AU2019901261A0 (en) Compositions and Methods of Treatment
HK40102245A (en) Dsg2 compositions and methods for the treatment of covid-19